Abiopharma

iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity

Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

Arianne Phosphate Executes Joint Venture Framework Agreement with Travertine Technologies

Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy

X-energy Submits Xe-100 HTGR for UK Generic Design Assessment

Fury Reports 7.86 g/t Gold Over 9.43 Metres in Infill Drilling at the Eau Claire Gold Project, Quebec

Accenture to Announce Third-Quarter Fiscal 2026 Results

Bowman Secures Significant Mining-Related Awards

Signet Jewelers Reports First Quarter Fiscal 2027 Results

Dollar General Corporation Reports First Quarter 2026 Results